Survey respondents represented 21 of the 23 Duke CRUs in operation during the assessment period as well as each of the included CRP jobs, with a majority of respondents in the CRC role that makes up the largest percentage of our workforce. This evidence concerns the gene CRP and colorectal carcinoma.